HAART initiated at higher CD4 count slowed disease progression


Newly published article shows that highly active antiretroviral therapy initiated at CD4 cell counts between 350 cells/mcL and 499 cells/mcL was associated with slower disease progression when compared with a deferral strategy, according to new findings published in the Archives of Internal Medicine.
Timing of HAART Initiation and Clinical Outcomes in Human Immunodeficiency Virus Type 1 Seroconverterters
New data shows that compared with deferring in a given month, HAART initiation at CD4 cell counts less than 500/µL (but not 500-799/µL) was associated with slower disease progression. 

Read more: http://archinte.ama-assn.org/cgi/content/abstract/171/17/1560